Our scientists and advisors are experts in immunoassay development. Our team began working together at Diagnostic Systems Laboratories (DSL) where we enjoyed 25 years of developing novel assays, exploring new biomarkers with key opinion leaders, developing intellectual property, and building relationships with our customers around the world. We excel at developing immunoassays from concept to fully validated assays. The efficiency of our monoclonal antibody development process enables us to produce and screen more antibodies to optimize pairs for a better immunoassay. Our core strength is research and development.